RISK OF RENAL-ALLOGRAFT REJECTION FOLLOWING ANGIOGRAPHY

[1] ISOLATION OF A FRAGMENT (C3A) OF THIRD COMPONENT OF HUMAN COMPLEMENT CONTAINING ANAPHYLATOXIN AND CHEMOTACTIC ACTIVITY AND DESCRIPTION OF AN ANAPHYLATOXIN INACTIVATOR OF HUMAN SERUM [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1969, 129 (05) : 1109 - &

[2] HENSON PM, 1974, TRANSPLANT P, V6, P27

[3] ACUTE REJECTION OF ALLOGENEIC TRANSPLANTED KIDNEYS FOLLOWING NEPHRECTOMY OF AUTOGENEIC PYELONEPHRITIC KIDNEYS [J]. TRANSPLANTATION, 1971, 11 (05) : 502 - &

[4] COMPLEMENT-MEDIATED VASOCONSTRICTION AND GRAFT REJECTION [J]. CIRCULATION RESEARCH, 1972, 30 (03) : 332 - +

[5] KISSMEYERNIELSE.E, 1967, HISTOCOMPATIBILITY T, P381

[6] CHANGES IN SERUM COMPLEMENT DURING THE COURSE AND TREATMENT OF GLOMERULONEPHRITIS [J]. ARCHIVES OF INTERNAL MEDICINE, 1951, 88 (04) : 433 - 445

[7] LASSER EC, 1974, INVEST RADIOL, V9, P216

[8] Nilson A E, 1968, Scand J Urol Nephrol, V2, P46, DOI 10.3109/00365596809133562

[9] POLLEY MJ, 1971, J IMMUNOL, V107, P1493

[1] ISOLATION OF A FRAGMENT (C3A) OF THIRD COMPONENT OF HUMAN COMPLEMENT CONTAINING ANAPHYLATOXIN AND CHEMOTACTIC ACTIVITY AND DESCRIPTION OF AN ANAPHYLATOXIN INACTIVATOR OF HUMAN SERUM [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1969, 129 (05) : 1109 - &

[2] HENSON PM, 1974, TRANSPLANT P, V6, P27

[3] ACUTE REJECTION OF ALLOGENEIC TRANSPLANTED KIDNEYS FOLLOWING NEPHRECTOMY OF AUTOGENEIC PYELONEPHRITIC KIDNEYS [J]. TRANSPLANTATION, 1971, 11 (05) : 502 - &

[4] COMPLEMENT-MEDIATED VASOCONSTRICTION AND GRAFT REJECTION [J]. CIRCULATION RESEARCH, 1972, 30 (03) : 332 - +

[5] KISSMEYERNIELSE.E, 1967, HISTOCOMPATIBILITY T, P381

[6] CHANGES IN SERUM COMPLEMENT DURING THE COURSE AND TREATMENT OF GLOMERULONEPHRITIS [J]. ARCHIVES OF INTERNAL MEDICINE, 1951, 88 (04) : 433 - 445

[7] LASSER EC, 1974, INVEST RADIOL, V9, P216

[8] Nilson A E, 1968, Scand J Urol Nephrol, V2, P46, DOI 10.3109/00365596809133562

[9] POLLEY MJ, 1971, J IMMUNOL, V107, P1493